Madrigal Pharmaceuticals
$502.47
64
-$16.19-3.12% Tuesday 20:00
Statistics
Day High
522.01
Day Low
497.23
52W High
602.83
52W Low
267.56
Volume
331,045
Avg. Volume
-
Mkt Cap
11.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6MayExpected
Expected EPS
-4.229637
Actual EPS
N/A
Financials
-30.08%Profit Margin
Unprofitable1.92BRevenue
-576.57MNet Income
Analyst Ratings
667.63Average Price Target
The highest estimate is 900.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 75%
Hold 25%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MDGL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Viking Therapeutics
VKTX
Mkt Cap3.48B
Gilead Sciences
GILD
Mkt Cap163.4B
Galmed Pharmaceuticals
GLMD
Mkt Cap3.77M
Agios Pharmaceuticals
AGIO
Mkt Cap1.67B
Axsome Therapeutics
AXSM
Mkt Cap10.62B
Novartis
NVS
Mkt Cap279.67B
About
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Show more...
CEO
Mr. William J. Sibold
Employees
528
Country
United States
ISIN
US5588681057
Listings
0 Comments
Share your thoughts
FAQ
What is Madrigal Pharmaceuticals stock price today?▼
The current price of MDGL is $502.47 USD — it has decreased by -3.12% in the past 24 hours. Watch Madrigal Pharmaceuticals stock price performance more closely on the chart.
What is Madrigal Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Madrigal Pharmaceuticals stocks are traded under the ticker MDGL.
Is Madrigal Pharmaceuticals stock price growing?▼
MDGL stock has fallen by -3.11% compared to the previous week, the month change is a -5.88% fall, over the last year Madrigal Pharmaceuticals has showed a +70.25% increase.
What is Madrigal Pharmaceuticals market cap?▼
Today Madrigal Pharmaceuticals has the market capitalization of 11.53B
What is Madrigal Pharmaceuticals revenue for the last year?▼
Madrigal Pharmaceuticals revenue for the last year amounts to 1.92B USD.
What is Madrigal Pharmaceuticals net income for the last year?▼
MDGL net income for the last year is -576.57M USD.
How many employees does Madrigal Pharmaceuticals have?▼
As of May 06, 2026, the company has 528 employees.
In which sector is Madrigal Pharmaceuticals located?▼
Madrigal Pharmaceuticals operates in the Health & Wellness sector.
When did Madrigal Pharmaceuticals complete a stock split?▼
The last stock split for Madrigal Pharmaceuticals was on July 25, 2016 with a ratio of 1:35.
Where is Madrigal Pharmaceuticals headquartered?▼
Madrigal Pharmaceuticals is headquartered in West Conshohocken, United States.